Asian Spectator


The Times

.

OTR Therapeutics and Zealand Pharma enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases

  • Written by PR Newswire Asia - Asian Spectator
  • Collaboration will combine Zealand Pharma's expertise in obesity and metabolic health with OTR Therapeutics' proprietary oral small-molecule platform and strong drug discovery capabilities, to discover and develop novel therapeutics for multiple targets in metabolic diseases
  • OTR Therapeutics will receive an initial upfront payment of USD 20 million,...

Magazine

Compressed Air Pipe and Fittings: What Every Australian Industrial Facility Needs to Know

Compressed air is the fourth utility of modern industry, right alongside electricity, gas, and water. Yet despite its critical role in powering everything from pneumatic tools to automated productio...

Common Risks Hidden in Commercial Lease Agreements

Commercial leases are often longer and more complex than tenants expect, and the fine print can carry significant financial and operational consequences over the years that follow. Many business own...

Corporate Secretarial Services in Singapore: Annual Compliance, Key Filings, and Common Mistake

Annual compliance in Singapore should not be treated as a once-a-year administrative event. It is an ongoing governance system that depends on accurate records, timely filings, disciplined approvals...

hacklink hack forum hacklink film izle hacklink z-libraryDizipalStreamEastPadişahbetGalabetjojobetjojobetcasibomhttps://chantilly-montessori-school.vercel.app/esim senegalbetparkbetparktelegram下载zlibrary bookscasino en lignesuperbetinjojobetholiganbetjojobetmarsbahismariobetjojobetjojobetnakitbahiscasibomcasibomholiganbetholiganbetgrandpashabetgrandpashabet